{
    "code": "52026447",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026447",
    "time": "2022-02-25 03:53:00",
    "許可證字號": "衛部藥輸字第026447號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/10\/29",
    "發證\/登錄日期": "103\/10\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202644705",
    "中文品名": "&quot;邁蘭&quot;巴米索錠0.25毫克",
    "英文品名": "Pramipexole Dihydrochlrodie Tablets Mylan 0.25mg",
    "適應症": "治療自發性巴金森氏症的徵候及症狀、治療原發性腿部躁動症(PRIMARY RESTLESS LEGS SYNDROME)的症狀。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠ALU-ALU鋁箔盒裝 2-1000錠HDPE塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201118216  台灣邁蘭有限公司",
    "申請商地址": "臺北市信義區信義路５段7號27樓",
    "主製造廠": [
        {
            "": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "7600001520",
            "成分名稱": "PRAMIPEXOLE ( PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE)",
            "含量描述": "(equivalent to Pramipexole 0.18mg)",
            "含量": "0.2500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文仿單-Pramipexole巴米索0.25mg-104-12-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026447&Seq=001&Type=9"
        }
    ]
}